Retinoblastoma

+ -Text Size

Other Resources and References TOPICS

References: Retinoblastoma detailed guide

Dimaras H, Kimani K, Dimba EA. Retinoblastoma. Lancet. 2012;379:1436–1446.

Dome JS, Rodriguez-Galindo C, Spunt SL, Santana VM. Pediatric solid tumors: Retinoblastoma. In: Abeloff MD, Armitage JO, Niederhuber JE. Kastan MB, McKenna WG, eds. Abeloff’s Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier; 2008:2107–2112.

Dunkel IJ, Jubran RF, Gururangan S, et al. Trilateral retinoblastoma: Potentially curable with intensive chemotherapy. Pediatr Blood Cancer. 2010:54:384–387.

Gobin YP, Dunkel IJ, Marr BP, Brodie SE, Abramson DH. Intra-arterial chemotherapy for the management of retinoblastoma: Four-year experience. Arch Ophthalmol. 2011;129:732–737.

Howlader N, Noone AM, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER website, April 2013.

Hurwitz RL, Shields CL, Shields JA, et al. Retinoblastoma. In: Pizzo PA, Poplack DG, eds. Principles and Practice of Pediatric Oncology. 6th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011: 809–837.

Lin P, O’Brien JM. Frontiers in the management of retinoblastoma. Am J Ophthalmol. 2009;148:192–198.

Marees T, Moll AC, Imhof SM, et al. Risk of second malignancies in survivors of retinoblastoma: More than 40 years of follow-up. J Natl Cancer Inst. 2008;100:1771–1779.

National Cancer Institute. Physician Data Query (PDQ). Retinoblastoma Treatment. 2013. Accessed at www.cancer.gov/cancertopics/pdq/treatment/retinoblastoma/healthprofessional on August 15, 2013.

Rushlow DE, Mol BM, Kennett JY, et al. Characterisation of retinoblastomas without RB1 mutations: Genomic, gene expression, and clinical studies. Lancet Oncol. 2013;14:327–334.

Wang LL, Yustein J, Louis C, et al. Solid tumors of childhood: Retinoblastoma. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 9th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2011:1769–1771.

Wilson MW, Haik BG, Liu T, et al. Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma. Am J Ophthalmol. 2005;140:397–406.

Zhang J, Benavente CA, McEvoy J, et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature. 2012;481:329–334.


Last Medical Review: 12/05/2013
Last Revised: 12/05/2013